No Data
No Data
Biotricity Launches Direct-to-Consumer Heart Health Screening Service, HeartSecure, Making Heart Health Services Accessible in Response to the #1 Global Killer, Poising Company to Access the Growing Home Diagnostics Market
Biotricity Inc. (NASDAQ:BTCY), a forerunning Technology-as-a-Service (TaaS) company committed to disrupting the healthcare industry with cutting-edge medical and consumer diagnostic solutions, today announces the highly anticipated launch of its direct-to-consumer heart health screening program, HeartSecure.
Express News | Biotricity Sees Year-End Revenue Growth To Exceed 24% YoY; Loss From Operations To Decrease Over 40% YoY; Margins To Improve Over 10% YoY
Express News | Biotricity Inc: Expects FY Loss From Operations to Decrease by Over 40% YoY
Express News | Biotricity Inc: Expects FY Revenue Growth to Exceed 24% YoY
Biotricity Provides Year-End Guidance With Expectations to Meet Analyst Revenue Target and Beating Loss and Margin Targets
Company expects Loss from Operations to decrease by over 40% YoY and Margin Improvement by over 10% YoYREDWOOD CITY, CA / ACCESSWIRE / June 6, 2024 / Biotricity Inc. (NASDAQ:BTCY), a leading Technolog
Biotricity Preferred Shareholders Show Increased Commitment and Support of the Company by Converting Almost All Preferred A Shares Into Restricted Common Stock
REDWOOD CITY, CA / ACCESSWIRE / June 4, 2024 / Biotricity Inc.] (NASDAQ:BTCY), a leading Technology-as-a-Service (TaaS) company dedicated to disrupting the healthcare industry with cutting-edge medica